FLYNN JAMES E 1352546 Data last updated 2024-05-14 07:02:16 -0500 US CDT
Latest Holdings
Notice: Data summarized from Form 3,4,5 filings, which do not include holdings/transactions of investment institution(s), if any, managed by the reporter.
Non-derivative Transactions CSV download
Tips: type "code_s" to show transactions with code "S".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-06-20 | 2022-06-16 | 4 | Flynn James E | DIRECTOR BY DEPUTIZATION | holding | 1026243.0 | 0 | 354.17 | 0.0 | Through Deerfield Partners, L.P. | Common Stock | ACUTUS MEDICAL, INC. | NA | 28.98 (AFIB) | ||
| 2023-06-20 | 2022-06-16 | 4 | Flynn James E | DIRECTOR BY DEPUTIZATION | holding | 1622143.0 | 0 | 559.83 | 0.0 | Through Deerfield Private Design Fund Iii, L.P. | Common Stock | ACUTUS MEDICAL, INC. | NA | 28.98 (AFIB) | ||
| 2023-06-20 | 2022-06-16 | 2022-06-16 to 2023-06-15 | 4 | Flynn James E | DIRECTOR BY DEPUTIZATION | acq | 16800.0 | 80.68 | 5.8 | 0.0 | Through Deerfield Management Company, L.P. | Common Stock | ACUTUS MEDICAL, INC. | code A | 20822.0
|
28.98 (AFIB) |
| 2023-11-21 | 2023-11-17 | 4 | Flynn James E | DIRECTOR BY DEPUTIZATION | holding | 15811090.0 | 0 | 1410.47 | 0.0 | Through Deerfield Partners, L.P. | Class A Common Stock | CAREMAX, INC. | NA | 112.1 (CMAX) | ||
| 2023-11-21 | 2023-11-17 | 2023-11-17 | 4 | Flynn James E | DIRECTOR BY DEPUTIZATION | acq | 12123.0 | 100.0 | 1.08 | 0.0 | Through Deerfield Management Company, L.P. | Class A Common Stock | CAREMAX, INC. | code M | 12123.0 | 112.1 (CMAX) |
| 2024-02-08 | 2024-02-06 | 2024-02-06 | 4 | Flynn James E | POSSIBLE MEMBERS OF 10% GROUP | acq | 834254.0 | 100.0 | 0.0 | Through Deerfield Private Design Fund Iii, L.P. | Common Stock | FRACTYL HEALTH, INC. | code C | 834254.0
|
0.0 (GUTS) | |
| 2024-02-16 | 2024-02-16 | 2024-02-16 | 4 | Flynn James E | * DIRECTOR BY DEPUTIZATION | acq | 1430206.0 | 23.25 | 325.74 | 8.74 | Through Deerfield Private Design Fund Iv, L.P. | Common Stock | LARIMAR THERAPEUTICS, INC. | code P | 6151406.0 | 43.91 (LRMR) |
| 2024-02-16 | 2024-02-16 | 4 | Flynn James E | * DIRECTOR BY DEPUTIZATION | holding | 4721197.0 | 0 | 1075.3 | 0.0 | Through Deerfield Healthcare Innovations Fund, L.P. | Common Stock | LARIMAR THERAPEUTICS, INC. | NA | 43.91 (LRMR) | ||
| 2024-02-16 | 2024-02-16 | 2024-02-16 | 4 | Flynn James E | * DIRECTOR BY DEPUTIZATION | acq | 1430206.0 | 23.25 | 325.74 | 8.74 | Through Deerfield Private Design Fund Iii, L.P. | Common Stock | LARIMAR THERAPEUTICS, INC. | code P | 6151389.0 | 43.91 (LRMR) |
| 2024-02-16 | 2024-02-16 | 2024-02-16 | 4 | Flynn James E | * DIRECTOR BY DEPUTIZATION | acq | 1430205.0 | 33.99 | 325.74 | 8.74 | Through Deerfield Partners, L.P. | Common Stock | LARIMAR THERAPEUTICS, INC. | code P | 4207982.0 | 43.91 (LRMR) |
| 2024-03-08 | 2024-02-27 | 3 | Flynn James E | *POSSIBLE MEMBER OF 10% GROUP | holding | 11878863.0 | 0 | 893.77 | 0.0 | Through Deerfield Partners, L.P. | Class A Common Stock | ADAPTHEALTH CORP. | NA | 132.91 (AHCO) | ||
| 2024-03-08 | 2024-02-27 | 3 | Flynn James E | *POSSIBLE MEMBER OF 10% GROUP | holding | 20000.0 | 0 | 1.5 | 0.0 | Through Deerfield Management Company, L.P. | Class A Common Stock | ADAPTHEALTH CORP. | NA | 132.91 (AHCO) | ||
| 2024-03-08 | 2024-02-27 | 3 | Flynn James E | *POSSIBLE MEMBER OF 10% GROUP | holding | 1709077.0 | 0 | 128.59 | 0.0 | Through Deerfield Private Design Fund Iv, L.P. | Class A Common Stock | ADAPTHEALTH CORP. | NA | 132.91 (AHCO) | ||
| 2024-03-12 | 2024-03-08 | 2024-03-08 to 2024-03-12 | 4 | Flynn James E | *POSSIBLE MEMBER OF 10% GROUP | dsp | 350000.0 | 2.95 | 26.33 | 10.9 | Through Deerfield Partners, L.P. | Class A Common Stock | ADAPTHEALTH CORP. | code S | 11528863.0
|
132.91 (AHCO) |
| 2024-03-12 | 2024-03-08 | 4 | Flynn James E | *POSSIBLE MEMBER OF 10% GROUP | holding | 20000.0 | 0 | 1.5 | 0.0 | Through Deerfield Management Company, L.P. | Class A Common Stock | ADAPTHEALTH CORP. | NA | 132.91 (AHCO) | ||
| 2024-03-12 | 2024-03-08 | 4 | Flynn James E | *POSSIBLE MEMBER OF 10% GROUP | holding | 1709077.0 | 0 | 128.59 | 0.0 | Through Deerfield Private Design Fund Iv, L.P. | Class A Common Stock | ADAPTHEALTH CORP. | NA | 132.91 (AHCO) | ||
| 2024-03-19 | 2024-03-15 | 2024-03-15 | 4 | Flynn James E | *DIRECTOR BY DEPUTIZATION | acq | 3055049.0 | 100.0 | 664.43 | 0.0 | Through Deerfield Private Design Fund V, L.P. | Common Stock | BIOMX INC. | code A | 3055049.0 | 45.98 (PHGE) |
| 2024-03-19 | 2024-03-15 | 2024-03-15 | 4 | Flynn James E | *DIRECTOR BY DEPUTIZATION | acq | 3055049.0 | 100.0 | 664.43 | 0.0 | Through Deerfield Healthcare Innovations Fund Ii, L.P. | Common Stock | BIOMX INC. | code A | 3055049.0 | 45.98 (PHGE) |
Derivative Transactions
Tips: type "code_m" to show transactions with code "M".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-05-11 | 2023-05-09 | 2023-05-09 | 4 | Flynn James E | * DIRECTOR BY DEPUTIZATION | acq | 8300.0 | 100.0 | 1.92 | 5.09 | Through Deerfield Management Company, L.P. | Stock Option (Right To Buy) | LARIMAR THERAPEUTICS, INC. | code A | 8300.0 | 43.27 (LRMR) |
| 2023-06-12 | 2023-06-08 | 2023-06-08 | 4 | Flynn James E | DIRECTOR BY DEPUTIZATION | acq | 33750.0 | 100.0 | 3.03 | 0.0 | Through Deerfield Management Company, L.P. | Restricted Stock Units | CAREMAX, INC. | code A | 33750.0 | 111.37 (CMAX) |
| 2023-06-16 | 2023-06-15 | 2023-06-15 | 4 | Flynn James E | DIRECTOR BY DEPUTIZATION | acq | 30000.0 | 100 | 5.84 | 44.68 | Through Deerfield Management Company, L.P. | Stock Option (Right To Buy) | NUVALENT, INC. | code A | 15000.0
|
51.39 (NUVL) |
| 2023-06-20 | 2022-06-16 | 4 | Flynn James E | DIRECTOR BY DEPUTIZATION | holding | 2292507.0
|
0 | 791.18 | 2.45 | Through Deerfield Private Design Fund Iii, L.P. | Warrant To Purchase Common Stock | ACUTUS MEDICAL, INC. | NA | 28.98 (AFIB) | ||
| 2023-06-20 | 2022-06-16 | 4 | Flynn James E | DIRECTOR BY DEPUTIZATION | holding | 1920625.0
|
0 | 662.84 | 1.09 | Through Deerfield Partners, L.P. | Warrant To Purchase Common Stock | ACUTUS MEDICAL, INC. | NA | 28.98 (AFIB) | ||
| 2023-06-20 | 2022-06-16 | 2022-06-16 to 2023-06-15 | 4 | Flynn James E | DIRECTOR BY DEPUTIZATION | acq | 39200.0 | 100 | 13.53 | 0.67 | Through Deerfield Management Company, L.P. | Stock Option (Right To Buy) | ACUTUS MEDICAL, INC. | code A | 19600.0
|
28.98 (AFIB) |
| 2023-06-20 | 2022-06-16 | 4 | Flynn James E | DIRECTOR BY DEPUTIZATION | holding | 948.395 | 0 | 0.33 | 0.0 | Through Deerfield Partners, L.P. | Series A Common Stock Equivalent Convertible Preferred Stock | ACUTUS MEDICAL, INC. | NA | 28.98 (AFIB) | ||
| 2023-06-20 | 2022-06-16 | 4 | Flynn James E | DIRECTOR BY DEPUTIZATION | holding | 1816.446 | 0 | 0.63 | 0.0 | Through Deerfield Private Design Fund Iii, L.P. | Series A Common Stock Equivalent Convertible Preferred Stock | ACUTUS MEDICAL, INC. | NA | 28.98 (AFIB) | ||
| 2023-11-21 | 2023-11-17 | 2023-11-17 | 4 | Flynn James E | DIRECTOR BY DEPUTIZATION | dsp | 12123.0 | 100.0 | 1.08 | 0.0 | Through Deerfield Management Company, L.P. | Restricted Stock Units | CAREMAX, INC. | code M | 0.0 | 112.1 (CMAX) |
| 2024-02-01 | 2024-02-01 | 3 | Flynn James E | POSSIBLE MEMBER OF 10% GROUP | holding | 757548.0 | 0 | 0.0 | Through Deerfield Private Design Fund Iii, L.P. | Series C 2 Preferred Stock | FRACTYL HEALTH, INC. | NA | 0.0 (GUTS) | |||
| 2024-02-01 | 2024-02-01 | 3 | Flynn James E | POSSIBLE MEMBER OF 10% GROUP | holding | 76706.0 | 0 | 0.0 | Through Deerfield Private Design Fund Iii, L.P. | Series D Preferred Stock | FRACTYL HEALTH, INC. | NA | 0.0 (GUTS) | |||
| 2024-02-08 | 2024-02-06 | 2024-02-06 | 4 | Flynn James E | POSSIBLE MEMBERS OF 10% GROUP | dsp | 1625699.0 | 100.0 | 0.0 | Through Deerfield Private Design Fund Iii, L.P. | Series C 2 Preferred Stock | FRACTYL HEALTH, INC. | code C | 0.0 | 0.0 (GUTS) | |
| 2024-02-08 | 2024-02-06 | 2024-02-06 | 4 | Flynn James E | POSSIBLE MEMBERS OF 10% GROUP | dsp | 164612.0 | 100.0 | 0.0 | Through Deerfield Private Design Fund Iii, L.P. | Series D Preferred Stock | FRACTYL HEALTH, INC. | code C | 0.0 | 0.0 (GUTS) | |
| 2024-03-08 | 2024-02-27 | 3 | Flynn James E | *POSSIBLE MEMBER OF 10% GROUP | holding | 10610547.0 | 0 | 798.34 | 0.0 | Through Deerfield Private Design Fund Iv, L.P. | Series B 1 Convertible Preferred Stock | ADAPTHEALTH CORP. | NA | 132.91 (AHCO) | ||
| 2024-03-08 | 2024-02-27 | 3 | Flynn James E | *POSSIBLE MEMBER OF 10% GROUP | holding | 1795455.0 | 0 | 135.09 | 0.0 | Through Deerfield Partners, L.P. | Series B 1 Convertible Preferred Stock | ADAPTHEALTH CORP. | NA | 132.91 (AHCO) | ||
| 2024-03-08 | 2024-02-27 | 3 | Flynn James E | *POSSIBLE MEMBER OF 10% GROUP | holding | 1640981.0 | 0 | 123.47 | 11.5 | Through Deerfield Private Design Fund Iv, L.P. | Private Placement Warrants | ADAPTHEALTH CORP. | NA | 132.91 (AHCO) | ||
| 2024-03-19 | 2024-03-15 | 2024-03-15 | 4 | Flynn James E | *DIRECTOR BY DEPUTIZATION | acq | 53840.0 | 100.0 | 11.71 | 0.0 | Through Deerfield Healthcare Innovations Fund Ii, L.P. | Series X Non Voting Convertible Preferred Stock | BIOMX INC. | code A | 53840.0
|
45.98 (PHGE) |
| 2024-03-19 | 2024-03-15 | 2024-03-15 | 4 | Flynn James E | *DIRECTOR BY DEPUTIZATION | acq | 53840.0 | 100.0 | 11.71 | 0.0 | Through Deerfield Private Design Fund V, L.P. | Series X Non Voting Convertible Preferred Stock | BIOMX INC. | code A | 53840.0
|
45.98 (PHGE) |
a Sum of same type of securities in the form
b Relative to reporter's shares owned before (disposition) or after (acquisition) operation
c Relative to issuer's shares outstanding (1/10000)
d Average price for securities of the same type. Check the original form for detailed prices of multiple transactions
e Documented shares outstanding closest to the transaction date
Note: Corporate may change mapped CIK when merge or spin-off happen. Please report error if the ticker you searched for does not have up-to-date insider trading information.
Show up to records per table for current tier. Access Guide)